Read the docs
TI-2023-20216 Aliases CVE-2023-38958GHSA-42rx-hfpw-m45p

An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers…

Priority LOW 30CWE-863Published · Updated

Key facts

Attack vector
Network
Privileges required
None
User interaction
None
Attack complexity
Low
Impact type
Security bypass
Confidentiality · integrity · availability
None · Low · None
Fix status
No fix listed

Attack profile from CVSS 3.1 · NVD. Fix status from CNA. Impact type from CWE-863.

Summary

An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.00371 31st percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
None
Automatable
Yes
Technical impact
Partial

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
——all versions—No fix listedCNA
  • — Vendor— Affected all versions Fixed in — No fix listed CNA

CPE configurations NVD · 1

CPEVersionsRoleVendor
cpe:2.3:a:zkteco:bioaccess_ivs:3.3.1:*:*:*:*:*:*:*3.3.1VulnerableZKTeco
  • cpe:2.3:a:zkteco:bioaccess_ivs:3.3.1:*:*:*:*:*:*:* Versions 3.3.1 Vulnerable ·ZKTeco

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2023-38958
  2. 2026-10-03 Alias added: GHSA-42rx-hfpw-m45p

References

  • TI-2023-20213 ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability. CVSS 3.1CRITICAL 9.8
  • TI-2023-20215 A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated… CVSS 3.1HIGH 7.5
  • TI-2023-20214 ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive… CVSS 3.1HIGH 7.5

Sources